Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs61973924 | chr13:114838888 | C/T | 0.00012 | 170 | 25.53 | 25.52 | 3.17 | KM Plot |
PCPG | rs62045229 | chr15:56280869 | G/C | 8.43E-6 | 176 | 24.7 | 26.53 | 25.17 | KM Plot |
PCPG | rs62045232 | chr15:56284419 | A/G | 0.000455 | 176 | 24.85 | 26.53 | 21.55 | KM Plot |
PCPG | rs62045239 | chr15:56294642 | G/A | 0.000409 | 178 | 25 | 25.87 | 21.55 | KM Plot |
PCPG | rs62046379 | chr15:56299233 | G/A | 0.000475 | 174 | 24.85 | 26.53 | 21.55 | KM Plot |
PCPG | rs62046381 | chr15:56300281 | T/G | 0.000409 | 178 | 25 | 25.87 | 21.55 | KM Plot |
PCPG | rs62046383 | chr15:56303623 | C/T | 0.000409 | 178 | 25 | 25.87 | 21.55 | KM Plot |
PCPG | rs62046386 | chr15:56305252 | G/A | 0.000418 | 177 | 25 | 26.53 | 21.55 | KM Plot |
PCPG | rs62046389 | chr15:56307688 | T/G | 0.000443 | 177 | 25 | 25.7 | 21.55 | KM Plot |
PCPG | rs62046390 | chr15:56308506 | G/A | 7.42E-6 | 177 | 24.85 | 26.53 | 25.17 | KM Plot |
PCPG | rs62046391 | chr15:56310688 | C/T | 0.000418 | 177 | 25 | 26.53 | 21.55 | KM Plot |
PCPG | rs62046392 | chr15:56312554 | C/G | 0.000418 | 177 | 25 | 26.53 | 21.55 | KM Plot |
PCPG | rs62046393 | chr15:56315385 | A/G | 0.000453 | 176 | 25 | 25.87 | 21.55 | KM Plot |
PCPG | rs62046394 | chr15:56316356 | C/A | 0.000453 | 176 | 25 | 25.87 | 21.55 | KM Plot |
PCPG | rs62046397 | chr15:56321302 | G/A | 7.6E-6 | 177 | 24.85 | 26.53 | 25.17 | KM Plot |